Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
Clinical trial NCT06711887 · RECRUITING
Trial details
- NCT number
- NCT06711887
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-19
- Primary completion
- 2035-08-01
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.